Smith et al., Biochemistry, vol. 20, pp. 1241-1245, (1981). |
Tseng, C. P., "Studies in Synthetic Heterocyclic Chemistry" pp. 171-185, (1979). |
Mulvery et al., J. Org. Chem., vol. 29, pp. 2903-2907, (1982). |
Temple et al., J. Org. Chem., vol. 47, pp. 761-765, (1982). |
Piper et al., J. Org. Chem., vol. 42, No. 2, pp. 208-211, (1977). |
Temple et al., "Synthesis of Potential Anticancer Agents", Report 85, pp. 1 & 2, (1966), Report 86, pp. 8 & 10, (1967). |
Scanlon et al., Molecular Pharmacology, vol. 16, pp. 261-269, (1979). |
Irwin et al., Advanced Heterocyclic Chemistry, vol. 10, pp. 149-171, (1969). |
Bird et al., Molecular Pharmacology, vol. 6, pp. 573-575, (1970). |
Trattner et al., J. Org. Chem., vol. 29, pp. 2674-2677, (1964). |
Hurst, "An Introduction to the Chemistry and Biochemistry of Pyrimidines, Purines and Pteridines", p. 231, John Wiley & Sons, (1980). |
Srinivasan et al., J. Org. Chem., vol. 45, pp. 3746-3748, (1980). |
Bennett et al., J. Med. Chem., vol. 24, pp. 382-389, (1981). |
Robins et al, J. Am. Chem. Soc., vol. 77, pp. 2256-2260, (1955). |
Calvert et al., European J. Cancer, vol. 16, pp. 713-722, (1980). |
Tseng, Dissertation Abstracts Int. B., vol. 40, p. 3752, (1980). |
Bernetti et al., J. Org. Chem., vol. 27, pp. 2863-2865, (1962). |
Hurlbert et al., J. Med. Chem., vol. 11, pp. 708-710, (1968). |
Arnold et al., Coll. Czech. Chem. Comm., vol. 25, pp. 1318-1323, (1980). |
Arnold, Coll. Czech. Chem. Comm., vol. 26, pp. 3051-3057, (1961). |
Stark et al., Tetrahedron, vol. 29, pp. 2209-2217, (1973). |
Elslager et al., "Lectures in Heterocyclic Chemistry", vol. 2, pp. S-97, S-119-S-121, (1974). |
Jones et al., European J. Cancer, vol. 17, pp. 11-19, (1981). |
Rizkalla et al., J. Org. Chem., vol. 37, No. 25, pp. 3980-3985, (1972). |
Grivsky et al., J. Med. Chem., vol. 23, pp. 327-329, (1980). |